Mesalamine 0.375gm Capsules

Manufacturer ZYDUS Active Ingredient Mesalamine Long-Acting Capsules (Apriso)(me SAL a meen) Pronunciation me SAL a meen
It is used to treat ulcerative colitis. It is used to help keep ulcerative colitis flares from coming back.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Anti-inflammatory agent
đŸ§Ŧ
Pharmacologic Class
Aminosalicylate; 5-aminosalicylic acid (5-ASA) derivative
🤰
Pregnancy Category
Not available
✅
FDA Approved
Oct 2008
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Mesalamine is a medication used to treat and prevent flare-ups of ulcerative colitis, a chronic inflammatory bowel disease. It works by reducing inflammation in the colon. Apriso is a special capsule that releases the medicine slowly as it travels through your digestive system, primarily in the colon.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, but be sure to swallow it whole with a full glass of water. Do not chew, open, or crush the medication. If you have difficulty swallowing, consult your doctor for guidance.

Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better. However, do not take antacids at the same time as this medication. If you need to take antacids, talk to your doctor about the best timing.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, avoiding the bathroom. Some products may come with a desiccant (a moisture-protecting packet) in the container. If your container has a desiccant, keep it in the bottle. If you're unsure about storing your medication without the desiccant, consult your doctor or pharmacist. Keep all medications in a safe place, out of the reach of children and pets.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed dose.
💡

Lifestyle & Tips

  • Take Apriso capsules whole with food, once daily. Do not crush, chew, or break the capsules.
  • Take the medication consistently as prescribed, even if you feel better, to maintain remission.
  • Stay well-hydrated, especially if you experience diarrhea.
  • Report any new or worsening symptoms to your doctor, including changes in urine output, yellowing of skin/eyes, unexplained bleeding/bruising, or severe abdominal pain.
  • Avoid taking antacids or other medications that significantly alter stomach pH around the same time as Apriso, as this could affect its release.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 1.5 g (four 0.375 g capsules) orally once daily with food
Dose Range: 1.5 - 1.5 mg

Condition-Specific Dosing:

ulcerative_colitis_maintenance: 1.5 g (four 0.375 g capsules) orally once daily with food
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for children under 10 years of age
Adolescent: For patients 10 years of age and older: 1.5 g (four 0.375 g capsules) orally once daily with food for maintenance of remission of ulcerative colitis.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Use with caution; monitor renal function.
Moderate: Use with caution; monitor renal function. Consider dose reduction or discontinuation if renal function worsens.
Severe: Contraindicated in patients with severe renal impairment (CrCl < 30 mL/min).
Dialysis: Not recommended; contraindicated in severe renal impairment.

Hepatic Impairment:

Mild: Use with caution; monitor liver function.
Moderate: Use with caution; monitor liver function. No specific dose adjustments provided, but close monitoring is warranted.
Severe: Use with caution; monitor liver function. Not studied in severe hepatic impairment.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Mesalamine (5-aminosalicylic acid) is thought to exert its anti-inflammatory effects locally in the colon. Its exact mechanism is not fully understood but is believed to involve inhibition of prostaglandin synthesis (via cyclooxygenase inhibition) and leukotriene synthesis (via lipoxygenase inhibition), scavenging of free radicals and reactive oxygen metabolites, and inhibition of inflammatory cell migration and cytokine production. The Apriso formulation is designed to deliver mesalamine to the colon.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 10-30% systemically absorbed (low)
Tmax: 4-12 hours (for parent drug and metabolite)
FoodEffect: Food significantly increases the systemic exposure of mesalamine and its metabolite (N-acetyl-5-ASA) when Apriso is administered. Apriso should be taken with food.

Distribution:

Vd: Not widely reported for systemic distribution due to local action; acts primarily in the colon.
ProteinBinding: Mesalamine: Approximately 43%; N-acetyl-5-ASA: Approximately 78%
CnssPenetration: Limited

Elimination:

HalfLife: Mesalamine: Approximately 7-12 hours; N-acetyl-5-ASA: Approximately 9-12 hours
Clearance: Not precisely quantified for local action; systemic clearance is primarily renal.
ExcretionRoute: Primarily renal (as N-acetyl-5-ASA metabolite); some fecal excretion of unabsorbed drug.
Unchanged: < 1% (systemically absorbed mesalamine)
âąī¸

Pharmacodynamics

OnsetOfAction: Clinical improvement typically seen within 3-21 days, but full therapeutic effect may take several weeks.
PeakEffect: Not directly applicable as it's a locally acting anti-inflammatory; clinical peak effect relates to symptom control.
DurationOfAction: Designed for once-daily dosing, providing sustained release throughout the colon.
Confidence: High

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to urinate or changes in urine output
+ Blood in the urine or significant weight gain
+ Back pain, abdominal pain, or blood in the urine (which may indicate a kidney stone)
Chest pain or pressure, rapid or irregular heartbeat
Fever, chills, sore throat, unexplained bruising or bleeding, or feeling extremely tired or weak
Symptoms that may resemble ulcerative colitis, such as:
+ New or worsening stomach pain or cramps
+ Bloody stools
+ Fever
+ Headache
+ Itching or rash
+ Red or pink eyes
+ General feeling of illness
Signs of liver problems, which can be rare but potentially life-threatening:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of heart problems, which can be rare but potentially life-threatening:
+ Shortness of breath
+ Significant weight gain
+ Swelling in the arms or legs
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect skin and organs
+ Symptoms may include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people experience no side effects or only mild ones. However, if you notice any of the following side effects or if they persist or bother you, contact your doctor:

Constipation
Diarrhea
Stomach pain or upset stomach
Vomiting
Heartburn
Gas
Burping
Nose or throat irritation
Dizziness or headache
Back pain
* Cough

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe abdominal pain, cramping, or bloody diarrhea (may indicate acute intolerance syndrome or worsening UC)
  • Signs of kidney problems: decreased urination, swelling in feet/ankles, unusual tiredness
  • Signs of liver problems: yellowing of skin or eyes (jaundice), dark urine, persistent nausea/vomiting, severe stomach pain
  • Signs of pancreatitis: severe pain in your upper stomach spreading to your back, nausea, vomiting
  • Signs of heart inflammation (myocarditis/pericarditis): chest pain, shortness of breath, palpitations
  • Signs of blood problems: unusual bleeding or bruising, fever, sore throat, fatigue
  • New or worsening skin rash, fever, or swollen lymph nodes (may indicate drug reaction with eosinophilia and systemic symptoms - DRESS syndrome)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
Certain health conditions, including:
+ Kidney disease or liver disease
+ Stomach or bowel ulcers
+ Narrowing of the stomach valve or other types of stomach blockages
+ Blockages in the urinary tract (consult with your healthcare provider if you have this condition)

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your existing health conditions and medications.

Remember, do not start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Be sure to discuss any concerns or questions with your doctor.

This medication may interfere with certain laboratory tests, so it is crucial to notify all your healthcare providers and laboratory personnel that you are taking this drug.

To stay hydrated, drink plenty of non-caffeinated fluids, unless your doctor advises you to limit your fluid intake.

If you have phenylketonuria (PKU), consult with your doctor before taking this medication, as some products may contain phenylalanine.

While taking this medication, you may notice that your urine turns reddish-brown when it comes into contact with surfaces or water that have been treated with bleach, such as in the toilet. However, if you notice that your urine is reddish-brown before it comes into contact with any surfaces or water, contact your doctor.

You may be more susceptible to sunburn while taking this medication. To protect yourself, avoid exposure to the sun, sunlamps, and tanning beds, and use sunscreen and wear protective clothing and eyewear when going outside.

If you are 65 years or older, use this medication with caution, as you may be more prone to side effects.

Not all formulations of this medication are suitable for children. Before giving this medication to a child, consult with your doctor to determine the appropriate dosage and potential risks.

Do not give this medication to children or teenagers who have or are recovering from flu symptoms, chickenpox, or other viral infections, as it may increase the risk of Reye's syndrome, a condition that can cause severe brain and liver damage.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor, as they will need to discuss the potential benefits and risks of this medication with you and determine the best course of action for you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Headache
  • Drowsiness
  • Vertigo
  • Tinnitus
  • Confusion
  • Hyperventilation (rare, but possible with very high doses)

What to Do:

In case of suspected overdose, seek immediate medical attention or call a Poison Control Center (1-800-222-1222). Treatment is generally supportive and symptomatic. There is no specific antidote.

Drug Interactions

🔴

Major Interactions

  • Azathioprine
  • Mercaptopurine (6-MP)
🟡

Moderate Interactions

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Nephrotoxic agents (e.g., tacrolimus, cyclosporine, aminoglycosides)
  • Lactulose (and other drugs that lower stool pH)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Renal function (serum creatinine, BUN)

Rationale: To establish baseline and identify pre-existing renal impairment, as mesalamine can cause renal toxicity.

Timing: Prior to initiation of therapy

Liver function tests (ALT, AST, bilirubin)

Rationale: To establish baseline and identify pre-existing hepatic impairment, as mesalamine can cause hepatotoxicity.

Timing: Prior to initiation of therapy

Complete Blood Count (CBC) with differential

Rationale: To establish baseline, especially if co-administering with thiopurines (azathioprine, mercaptopurine) due to increased risk of myelosuppression.

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Renal function (serum creatinine, BUN)

Frequency: Annually, or more frequently if clinically indicated (e.g., in elderly, those with pre-existing renal disease, or on concomitant nephrotoxic drugs).

Target: Within normal limits or stable from baseline.

Action Threshold: Significant increase in creatinine or BUN; consider dose adjustment or discontinuation.

Liver function tests (ALT, AST, bilirubin)

Frequency: Periodically, or if symptoms of hepatic dysfunction develop.

Target: Within normal limits or stable from baseline.

Action Threshold: Significant elevation; consider discontinuation.

Complete Blood Count (CBC) with differential

Frequency: Periodically, especially if co-administered with azathioprine or mercaptopurine (e.g., every 3-6 months or as clinically indicated).

Target: Within normal limits.

Action Threshold: Significant decrease in white blood cell count, platelet count, or hemoglobin; consider discontinuation.

đŸ‘ī¸

Symptom Monitoring

  • Worsening of ulcerative colitis symptoms (e.g., increased frequency of bowel movements, rectal bleeding, abdominal pain)
  • Signs of renal impairment (e.g., decreased urine output, swelling in ankles/feet, fatigue)
  • Signs of hepatic impairment (e.g., yellowing of skin/eyes, dark urine, persistent nausea/vomiting, abdominal pain)
  • Signs of hypersensitivity reactions (e.g., rash, fever, difficulty breathing, chest pain, pericarditis, myocarditis)
  • Signs of acute intolerance syndrome (e.g., abdominal pain, cramping, bloody diarrhea, fever, headache, rash)
  • Signs of pancreatitis (e.g., severe abdominal pain radiating to the back, nausea, vomiting)
  • Signs of blood dyscrasias (e.g., unusual bruising or bleeding, persistent sore throat, fever, fatigue)

Special Patient Groups

🤰

Pregnancy

Mesalamine is generally considered low risk during pregnancy. Available data from published studies, postmarketing reports, and pregnancy registries over several decades have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. However, some studies suggest a potential for increased risk of preterm birth and low birth weight, though confounding factors are often present. Use only if clearly needed.

Trimester-Specific Risks:

First Trimester: No clear evidence of increased risk of major birth defects.
Second Trimester: No clear evidence of increased risk of adverse outcomes.
Third Trimester: No clear evidence of increased risk of adverse outcomes, but monitor for potential renal dysfunction in the neonate if maternal exposure is high or prolonged.
🤱

Lactation

Mesalamine and its active metabolite (N-acetyl-5-ASA) are excreted in human milk in small amounts. While generally considered compatible with breastfeeding, monitor breastfed infants for signs of diarrhea. If diarrhea develops, discontinue breastfeeding or the drug.

Infant Risk: Low; monitor for diarrhea.
đŸ‘ļ

Pediatric Use

Apriso is approved for the maintenance of remission of ulcerative colitis in pediatric patients 10 years of age and older. Safety and effectiveness have not been established in pediatric patients younger than 10 years of age.

👴

Geriatric Use

No specific dose adjustments are required based on age alone. However, elderly patients are more likely to have decreased renal function, so monitoring of renal function is particularly important in this population. Use with caution in elderly patients with known or suspected renal impairment.

Clinical Information

💎

Clinical Pearls

  • Apriso is a delayed-release, extended-release formulation of mesalamine designed for once-daily dosing and targeted delivery to the colon. It must be taken with food.
  • Patients should swallow the capsules whole and not crush, chew, or break them, as this will compromise the extended-release properties.
  • Mesalamine can cause renal impairment, including interstitial nephritis. Regular monitoring of renal function is crucial, especially in patients with pre-existing renal disease, elderly patients, or those on concomitant nephrotoxic drugs.
  • An acute intolerance syndrome resembling a flare of inflammatory bowel disease has been reported with mesalamine. Symptoms include cramping, acute abdominal pain, bloody diarrhea, fever, headache, and rash. If this occurs, discontinue therapy immediately.
  • Caution is advised when co-administering mesalamine with azathioprine or mercaptopurine due to an increased risk of myelosuppression. Monitor CBC closely.
  • Mesalamine can interfere with laboratory tests for normetanephrine, potentially leading to falsely elevated results.
🔄

Alternative Therapies

  • Other oral mesalamine formulations (e.g., Lialda, Asacol HD, Pentasa, Delzicol)
  • Rectal mesalamine formulations (e.g., Rowasa enema, Canasa suppositories)
  • Corticosteroids (e.g., prednisone, budesonide)
  • Immunomodulators (e.g., azathioprine, mercaptopurine, methotrexate)
  • Biologic agents (e.g., infliximab, adalimumab, vedolizumab, ustekinumab)
  • Janus kinase (JAK) inhibitors (e.g., tofacitinib, upadacitinib)
💰

Cost & Coverage

Average Cost: Varies widely, typically high for brand-name per 30 capsules
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (Specialty/Non-preferred Brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.